Insulin lispro 200 units/ml (Humalog)

High Strength, Fixed Combination and Biosimilar Insulin Products: Minimising the Risk of Medication Error

A new document has been posted on the NECS MO website.
High Strength, Fixed Combination and Biosimilar Insulin Products: Minimising the Risk of Medication Error. This is a briefing document which summarises the current guidance and recommendations on ways to minimise the risk of medication errors with newer insulin preparations.

read more about High Strength, Fixed Combination and Biosimilar Insulin Products: Minimising the Risk of Medication Error